Association of risk assessment at diagnosis with healthcare resource utilization and health‐related quality of life outcomes in pulmonary arterial hypertension

Documenti analoghi

• Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real‐world data analysis
  di: Tracey Weiss, et al.
  Pubblicazione: (2024)
• Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY)
  di: Grzegorz Kopeć, et al.
  Pubblicazione: (2024)
• Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
  di: Salaheldin Ahmed, et al.
  Pubblicazione: (2024)
• Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER‐MRI studies
  di: Allan Lawrie, et al.
  Pubblicazione: (2024)
• Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
  di: André Carramenha de Góes Hirano
  Pubblicazione: (2017)